Mayzent (Siponimod)

New Topic

9 topics • Page 1 of 1

Topics

Replies

Views

Last post

Mayzent prescribing information

Last post by NHE « Thu Apr 25, 2019 12:30 pm

by NHE » Thu Apr 25, 2019 12:30 pm

Mayzent prescribing information.

0 Replies

1046 Views

Last post by NHE
Thu Apr 25, 2019 12:30 pm
Siponimod reduces risk of disability progression by 21%

Last post by Zyklon « Sat Apr 27, 2019 4:27 pm
Replies: 2
by MSUK » Tue May 09, 2017 12:15 am

First post

Scientists who conducted a randomised, double-blind, placebo-controlled, phase III study, evaluating siponimod versus a placebo in patients with...

Last post

I agree with NHE. Not much improvement and lots of possible side effects.

2 Replies

3579 Views

Last post by Zyklon
Sat Apr 27, 2019 4:27 pm
RE; NEW DRUG SHOWN TO SLOW PROGRSSION IN SPMS

Last post by frodo « Fri Apr 28, 2017 1:03 am
Replies: 1
by seeva » Tue Apr 25, 2017 3:10 am

First post

HI Friends please read

Siponimod can slow down the progression of secondary progressive MS, results from the EXPAND trial have revealed.

regards...

Last post

Great news. Thanks.

1 Replies

2766 Views

Last post by frodo
Fri Apr 28, 2017 1:03 am
Novartis announces positive results for Siponimod

Last post by MSUK « Thu Aug 25, 2016 1:07 am

by MSUK » Thu Aug 25, 2016 1:07 am

Novartis AG has said that a late-stage study has shown the oral, once-daily BAF312 drug, or Siponimod, reduced the risk of disability progression in...

0 Replies

1213 Views

Last post by MSUK
Thu Aug 25, 2016 1:07 am
Siponimod study in secondary-progressive multiple sclerosis

Last post by HarryZ « Mon Jan 27, 2014 6:34 am
Replies: 1
by MSUK » Mon Jan 27, 2014 5:30 am

First post

A new clinical trial is underway for individuals who have secondary progressive multiple sclerosis (SPMS). Patients with SPMS generally have had...

Last post

A new clinical trial is underway for individuals who have secondary progressive multiple sclerosis (SPMS). Patients with SPMS generally have had...

1 Replies

1892 Views

Last post by HarryZ
Mon Jan 27, 2014 6:34 am
Efficacy and safety of Siponimod (BAF312) in SPMS patients

Last post by seeva « Sun Jan 19, 2014 4:18 am

by seeva » Sun Jan 19, 2014 4:18 am

HI friends this trial's recruiting people with SPMS for the trial in sydney hospitals until may 2014 more details read the website
regards
seeva

0 Replies

2113 Views

Last post by seeva
Sun Jan 19, 2014 4:18 am
Siponimod for patients with relapsing-remitting MS

Last post by MSUK « Wed Jun 12, 2013 6:52 am

by MSUK » Wed Jun 12, 2013 6:52 am

Siponimod for patients with relapsing-remitting MS (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

Background
Siponimod is an oral...

0 Replies

1717 Views

Last post by MSUK
Wed Jun 12, 2013 6:52 am
Novartis To Present New Data On Multiple Sclerosis Treatment

Last post by MSUK « Wed Mar 13, 2013 12:46 am

by MSUK » Wed Mar 13, 2013 12:46 am

Novartis AG said it will present new data on Multiple Sclerosis or MS treatment at the 65th annual meeting of the American Academy of Neurology or...

0 Replies

3587 Views

Last post by MSUK
Wed Mar 13, 2013 12:46 am
Positive phase IIb data for BAF312 (siponimod) in MS

Last post by MSUK « Fri Apr 20, 2012 2:35 am

by MSUK » Fri Apr 20, 2012 2:35 am

At the 64th annual meeting of the American Academy of Neurology (AAN) Novartis will present the key results from a phase II dose finding study of its...

0 Replies

2838 Views

Last post by MSUK
Fri Apr 20, 2012 2:35 am

New Topic

9 topics • Page 1 of 1

Return to Board Index

Forum permissions

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum